Passage Bio, Inc., a biotechnology firm specializing in biological products, has transferred its stock listing from The Nasdaq Global Select Market to The Nasdaq Capital Market. The transition, ...

Metsera and Maze Therapeutics priced their Nasdaq IPOs, raising $275M and $140M respectively. Both companies backed by ARCH ...

The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

San Francisco, California-- (Newsfile Corp. - January 30, 2025) - BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from ...

Stallion India Fluorochemicals IPO Day 2: Stallion India Fluorochemicals Ltd began its IPO on January 16 to raise ₹199.45 crore, receiving a 7.08x subscription on the first day. (https ...

Bio-Rad Laboratories ... You can see the complete list of today’s Zacks #1 Rank stocks here. Haemonetics, carrying a Zacks Rank #2 at present, has an estimated fiscal 2025 earnings growth ...

Stallion India Fluorochemicals IPO Day 2 Highlights: The initial public offer of Stallion India IPO closed for subscription on the second day on Friday, garnering 32.12 times bids amid strong ...

When we introduced the Nasdaq IPO Pulse a year ago, we said it suggested that U.S. “IPO activity… should remain in an uptrend” as we headed into 2024. Then, when we introduced the Nasdaq ...

Laxmi Dental IPO allotment date is be in focus and the company is expected to finalise the basis of share allotment soon.(Image: Pixabay) Laxmi Dental IPO Allotment: The initial public offering ...

It was the biggest initial public offering (IPO) in history at the time ... Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks ...

So, the natural question for Generation Bio (NASDAQ:GBIO) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative ...